Cargando…
Divide and conquer: the genetic basis of molecular subclassification of breast cancer
Since the luminal B tumours are associated with poor recurrence-free and disease-specific survivals in all adjuvant systemic treatment categories including hormone therapy, the identification of specific signalling pathways driving luminal B biology is paramount to improve treatment. Sircoulomb et a...
Autor principal: | Kristensen, Vessela N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377072/ https://www.ncbi.nlm.nih.gov/pubmed/21394915 http://dx.doi.org/10.1002/emmm.201100128 |
Ejemplares similares
-
Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010) -
Decoding the evolution of a breast cancer genome
por: Bedard, Philippe L, et al.
Publicado: (2010) -
Circulating tumor DNA in early-stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
por: af Hällström, Taija M, et al.
Publicado: (2015) -
eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN
por: Russnes, Hege G, et al.
Publicado: (2014) -
Single stem cell gene therapy for genetic skin disease
por: Larsimont, Jean-Christophe, et al.
Publicado: (2015)